EANM procedure guidelines for therapy of benign thyroid disease

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 11, 2010, Pages 2218-2228

  Stokkel, Marcel P M ^e   Handkiewicz Junak, Daria ^a   Lassmann, Michael ^b   Dietlein, Markus ^c   Luster, Markus ^d  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e NONE

Author keywords

Adults; Benign thyroid disorders; Children; Guidelines; Radioiodine therapy; Radioiodine treatment

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CORTICOSTEROID; GLUCOCORTICOID; HYDROCORTISONE SODIUM SUCCINATE; IODINE 131; LITHIUM ACETATE; PERTECHNETIC ACID TC 99M; PREDNISONE; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE;

AUTOIMMUNE THYROIDITIS; CANCER RISK; DOSIMETRY; DYSPNEA; EYE DISEASE; FOLLOW UP; FORWARD HEART FAILURE; GRAVES DISEASE; HEART ARRHYTHMIA; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MYALGIA; NODULAR GOITER; PRACTICE GUIDELINE; PRURITUS; RADIATION DOSE; REVIEW; THYROID CARCINOMA; THYROID DISEASE; THYROID FUNCTION TEST; THYROID SURGERY; THYROID SWELLING; TOXIC GOITER; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URTICARIA;

ADULT; CHILD; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; NUCLEAR MEDICINE; PREGNANCY; RADIOMETRY; RADIOPHARMACEUTICALS; SOCIETIES, SCIENTIFIC; THYROID DISEASES;

EID: 77958457895     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1536-8     Document Type: Review

References (77)

1. MT McDermott WW Woodmansee BR Haugen, et al. 2003 The management of subclinical hyperthyroidism by thyroid specialists Thyroid 13 1133 1139 10.1089/10507250360731532 14751034
2. JE Freitas 2000 Therapeutic options in the management of toxic and nontoxic nodular goiter Semin Nucl Med 30 88 97 10.1053/nm.2000.4597 10787189
3. D Reinwein G Benker JH Lazarus WD Alexander the European multicenter study group on antithyroid drug treatment 1993 A prospective randomized trial of antithyroid drug dose in Graves' disease therapy J Clin Endocrinol Metab 76 1516 1521 10.1210/jc.76.6.1516 8501160
4. S Fast V Nielsen S Bonnema L Hegedus 2008 Time to reconsider nonsurgical therapy of benign nontoxic multinodular goitre. Focus on recombinant human TSH (rhTSH) augmented radioiodine therapy Eur J Endocrinol 160 517 528 10.1530/EJE-08-0779 19106244
5. E Papini L Petrucci R Guglielmi C Panunzi R Rinaldi V Bacci, et al. 1998 Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules J Clin Endocrinol Metab 83 780 783 10.1210/jc.83.3.780 9506726
6. MF Wesche MM Tiel-V Buul P Lips NJ Smits WM Wiersinga 2001 A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter J Clin Endocrinol Metab 86 998 1005 10.1210/jc.86.3.998 11238476
7. J Brunn U Block G Ruf I Bos WP Kunze PC Scriba 1981 Volumetric analysis of thyroid lobes by real-time ultrasound Dtsch Med Wochenschr 106 1338 1340 10.1055/s-2008-1070506 7274082
8. M Moschetta AA Ianora M Testini M Vacca A Scardapane G Angelelli 2010 Multidetector computed tomography in the preoperative evaluation of retrosternal goiters: a useful procedure for patients for whom magnetic resonance imaging is contraindicated Thyroid 20 181 187 10.1089/thy.2009.0107 20151825
9. DS Cooper GM Doherty BR Haugen RT Kloos SL Lee SJ Mandel, et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid. 19 1167 214 10.1089/thy.2009.0110 19860577
10. D Moka M Dietlein H Schicha 2002 Radioiodine therapy and thyrostatic drugs and iodine Eur J Nucl Med Mol Imaging 29 Suppl 2 S486 S491 10.1007/s00259-002-0868-4 12192550
11. RB Santos JH Romaldini LS Ward 2004 Propylthiouracil reduces the effectiveness of radioiodine treatment in hyperthyroid patients with Graves' disease Thyroid 14 525 530 10.1089/1050725041517093 15307942
12. SJ Bonnema FN Bennedbaek A Veje J Marving L Hegedus 2004 Propylthiouracil before I-131 therapy of hyperthyroid diseases; effect on cure rate evaluated by a randomized clinical trial J Clin Endocrinol Metab 89 4439 4444 10.1210/jc.2004-0247 15356044
13. M Braga N Walpert HB Burch BL Solomon DS Cooper 2002 The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial Thyroid 12 135 139 10.1089/105072502753522365 11916282
14. C Kobe I Weber W Eschner F Sudbrock M Schmidt M Dietlein, et al. 2008 Graves' disease and radioiodine therapy: is success of ablation dependent on the choice of thyreostatic medication? Nuklearmedizin 47 153 166 18690374
15. L Bartalena L Baldeschi A Dickinson A Eckstein P Kendall-Taylor C Marcocci European Group on Graves' Orbitopathy (EUGOGO), et al. 2008 Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO Eur J Endocrinol 158 273 285 10.1530/EJE-07-0666 18299459
16. SJ Bonnema L Bartelana AD Toft L Hegedus 2002 Controversies in radioiodine therapy: relation to ophthalmopathy the possible radioprotective effect of antithyroid drugs, and use in large goitres Eur J Endocrinol 147 1 11 10.1530/eje.0.1470001 12088914
17. SA Eskes WM Wiersinga 2009 Amiodarone and thyroid Best Practice Res Clin Endocrinol Metab 23 735 751 10.1016/j.beem.2009.07.001
18. F Bogazzi L Bartalena S Brogioni G Scarcello A Burelli A Compomori, et al. 1999 Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism J Clin Endocrinol Metab 84 499 530 10.1210/jc.84.2.499 10022407
19. CS Bal A Kumar RM Pandey 2002 A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism Thyroid 12 399 405 10.1089/105072502760043486 12097201
20. F Bogazzi L Bartalena A Compomori S Brogioni C Traino F DeMartino, et al. 2002 Treatment with Lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease J Clin Endocrinol Metab 87 4490 4495 10.1210/jc.2002-020580 12364424
21. MN Silva IG Rubió R Romão EM Gebrin C Buchpiguel E Tomimori, et al. 2004 Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres Clin Endocrinol (Oxf) 60 300 308 10.1046/j.1365-2265.2003.01918.x
22. S Fast VE Nielsen P Grupe SJ Bonnema L Hegedüs 2009 Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study J Nucl Med 50 732 737 10.2967/jnumed.108.060152 19403877
23. VE Nielsen SJ Bonnema L Hegedus 2006 Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign non-toxic nodular goiter: a randomized, double-blind, cross-over trial J Clin Endocrinol Metab 91 1317 1322 10.1210/jc.2005-2137 16434453
24. VE Nielsen SJ Bonnema H Boel-Jorgensen P Grupe L Hegedus 2006 Stimulation with 0.3 mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign non-toxic nodular goiter: a prospective randomized double-blind trial Arch Intern Med 166 1476 1482 10.1001/archinte. 166.14.1476 16864757
25. J Bachmann C Kobe S Bor I Rahlff M Dietlein H Schicha, et al. 2009 Radioiodine therapy for thyroid volume reduction of large goitres Nucl Med Commun 30 466 471 10.1097/MNM.0b013e32832b5ccc 19381116
26. T Cappelen JF Unhjem AL Amundsen G Kravdal I Følling 2006 Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131 Eur J Nucl Med Mol Imaging 33 81 86 10.1007/s00259-005-1888-7 16151768
27. W Koch F Rosa P Knesewitsch K Hahn 2005 Guideline on radiation protection in medicine requires documentation of radioiodine therapy and follow-up: what are the benefits of an electronic database? Nuklearmedizin 44 49 55 15861272
28. GL Dillehay NA Ellerbroek H Balon DR Brill PW Grigsby RM Macklis American Society for Therapeutic Radiology and Oncology, et al. 2006 Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources Int J Radiat Oncol Biol Phys 64 1299 1307 16472933
29. International Commission on Radiological Protection 2004 Release of patients after therapy with unsealed radionuclides Ann ICRP 34 1 79 Erratum in: Ann ICRP 2004; 34(3-4): 281. Ann ICRP 2006; 36(4):77
30. Royal College of Physicians of London. Radioiodine in themanagement of benignthyroid disease:clinical guidelines. London: RCP; 2007. http://www.rcplondon.ac.uk/pubs/contents/0621b67a-4880-4a1b-9942-57a666efee4a. pdf
31. M Dietlein J Dressler F Grünwald B Leisner E Moser C Reiners, et al. 2007 Guideline for radioiodine therapy for benign thyroid diseases (version 4) Nuklearmedizin 46 220 223 17938758
32. L Hegedus SJ Bonnema FN Bennedbaek 2003 Management of simple nodular goiter: current status and future perspectives Endocr Rev 24 102 132 10.1210/er.2002-0016 12588812
33. WA Nieuwlaat DA Huysmans HC van den Bosch CG Sweep HA Ross FH Corstens, et al. 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter J Clin Endocrinol Metab 88 3121 3129 10.1210/jc.2002-021554 12843153
34. M Dietlein J Dressler W Eschner M Lassman B Leisner C Reiners Deutsche Gesellschaft für Nuclearmedizin (DGN) und die Deutsche Gesellschaft für Medizinische Physik (DGMP), et al. 2007 Procedure guideline for radioiodine test (version 3) Nuklearmedizin 46 198 202 17938754
35. MG Stabin AB Brill 2008 State of the art in nuclear medicine dose assessment Semin Nucl Med 38 308 320 10.1053/j.semnuclmed.2008.05.005 18662553
36. M Salvatori M Luster 2010 Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma Eur J Nucl Med Mol Imaging 37 821 828 10.1007/s00259-010-1398-0 20186542
37. C Kobe W Eschner M Wild I Rahlff F Sudbrock M Schmidt, et al. 2010 Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of I-131? Nucl Med Commun 31 201 205 10.1097/MNM.0b013e328333d303 19907353
38. AP Weetman 2007 Radioiodine treatment for benign thyroid diseases Clin Endocrinol 66 757 764 10.1111/j.1365-2265.2007.02841.x
39. A de Rooy JP Vandenbroucke JW Smit MP Stokkel OM Dekkers 2009 Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis Eur J Endocrinol 161 771 777 10.1530/EJE-09-0286
40. WD Leslie L Ward EA Salamon S Ludwig RC Rowe EA Cowden 2003 A randomized comparison of radioiodine in Graves' hyperthyroidism J Clin Endocrinol Metab 88 978 983 10.1210/jc.2002-020805 12629071
41. K Boeleart AA Syed N Manji MC Sheppard RL Holder SC Gough, et al. 2009 Prediction of cure and risk of hypothyroidism in patients receiving I-131 for hyperthyroidism Clin Endocrinol 70 129 138 10.1111/j.1365-2265.2008.03291.x
42. C Kobe W Eschner F Sudbrock I Weber K Marx M Dietlein, et al. 2008 Graves' disease and radioiodine therapy: is success of ablation dependent on the achieved dose above 200 Gy? Nuklearmedizin 47 13 17 18278207
43. JC Sisson AM Avram D Rubello MD Gross 2007 Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design of science? Eur J Nucl Med Mol Imaging 34 1129 1130 10.1007/s00259-007-0419-0 17457585
44. SA Rivkees C Dinauer 2007 An optimal treatment for pediatric Graves' disease is radioiodine J Clin Endocrinol Metab 92 797 800 10.1210/jc.2006-1239 17341574
45. M Chao X Jiawei W Guoming L Jianbin L Wanxia A Driedger, et al. 2009 Radioiodine treatment for pediatric hyperthyroid Graves' disease Eur J Pediatr 168 1165 1169 10.1007/s00431-009-0992-2 19421775
46. JA Franklyn P Maisonneuve M Sheppard J Betteridge P Boyle 1999 Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population based cohort study Lancet 353 2111 2115 10.1016/S0140-6736(98)12295-X 10382695
47. BM Dobyns GE Sheline JB Workman EA Tompkins WM McConahey DV Becker 1974 Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study J Clin Endocrinol Metab 38 976 998 10.1210/jcem-38-6-976 4134013
48. JD Boice Jr 2005 Radiation induced thyroid cancer - what's new? J Natl Cancer Inst 97 703 705 10.1093/jnci/dji151 15900034
49. P Hall LE Holm 1997 Late consequences of radioiodine for diagnosis and therapy in Sweden Thyroid 7 205 208 10.1089/thy.1997.7.205 9133685
50. E Cardis A Kesminiene V Ivanov I Malakhova Y Shibata V Khrouch, et al. 2005 Risk of thyroid cancer after exposure to I-131 in childhood J Natl Cancer Inst 97 724 732 10.1093/jnci/dji129 15900042
51. CH Read Jr MJ Tansey Y Menda 2004 A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients J Clin Endocrinol Metabol 89 4229 4233 10.1210/jc.2003-031223
52. C Reiners 2009 Radioactivity and thyroid cancer Hormones 8 185 192 19671517
53. E Ron MM Doody DV Becker BS Harris 3rd DA Hoffman WM McConahey, et al. 1998 Cancer mortality following treatment for adult hyperthyroidism. Cooperative thyrotoxicosis therapy follow-up study group JAMA 280 347 355 10.1001/jama.280.4.347 9686552
54. SA Rivkees EA Cornelius 2003 Influence of iodine-131 dose on the outcome of hyperthyroidism in children Pediatrics 111 745 749 10.1542/peds.111.4.745 12671107
55. SA Rivkees C Sklar M Freemark 1998 Clinical review: the management of Graves' disease in children, with special emphasis on radioiodine treatment J Clin Endocrinol Metab 83 3767 3776 10.1210/jc.83.11.3767 9814445
56. NS Glaser DM Styne 1997 Predictors of early remission of hyperthyroidism in children J Clin Endocrinol Metab 82 1719 1726 10.1210/jc.82.6.1719 9177370
57. Ma C, Kuang A, Xie J, Liu GJ. Radioiodine for pediatric Graves' disease. John Wiley & Sons, Ltd, 2009. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD006294. doi: 10.1002/14651858.CD006294.pub2
58. L Tallstedt G Lundell O Torring G Wallin JG Ljunggren H Blomgren, et al. 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group N Engl J Med 326 1733 1738 10.1056/NEJM199206253262603 1489388
59. L Bartalena C Marcocci F Bogazzi L Manetti ML Tanda E Dell'Unto, et al. 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy N Engl J Med 338 73 78 10.1056/NEJM199801083380201 9420337
60. P Hall G Lundell LE Holm 1993 Mortality in patients treated for hyperthyroidism with iodine-131 Acta Endocrinol (Copenh) 128 230 234
61. G Lucignani 2007 Long-term risks in hyperthyroid patients treated with radioiodine: is there anything new? Eur J Nucl Med Mol Imaging 34 1504 1509 10.1007/s00259-007-0509-z 17665195
62. PW Dickman LE Holm G Lundell Jr P Hall 2003 Thyroid cancer risk after thyroid examination with I-131: a population-based cohort study in Sweden Int J Cancer 106 580 587 10.1002/ijc.11258 12845656
63. D Sanyal P Mukhhopadhyay K Pandit J Chatterjee M Raychaudhuri S Mukherjee, et al. 2008 Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease J Indian Med Assoc 106 360 372 18839646
64. V Canadas L Vilar E Moura A Brito E Castellar 2007 Evaluation of radioiodine therapy with fixed doses of 10 and 15 mCi in patients with Graves' disease Arq Bras Endocrinol Metab 51 1069 1076 10.1590/S0004-27302007000700008
65. A Collier S Gosh M Hair I Malik J McGarvie 2009 Comparison of two fixed activities of radioiodine therapy (370 vs. 555 MBq) in patients with Graves' disease Hormones (Athens) 8 273 278
66. BE Jensen SJ Bonnema L Hegedues 2005 Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease Eur J Endocrinol 153 15 21 10.1530/eje.1.01924 15994741
67. S Dunkelmann H Kuenster E Nabavi B Rohde P Groth C Schuemichen 2007 Change in the intrathyroidal kinetics of radioiodine under continued and discontinued antithyroid medication in Graves' disease Eur J Nucl Med Mol Imaging 34 228 236 10.1007/s00259-006-0234-z 17021811
68. S Kubota H Ohye G Yano E Nishihara T Kudo M Ito, et al. 2006 Two-day thioamide withdrawal prior to radioiodine uptake sufficiently increases uptake and does not exacerbate hyperthyroidism compared to 7-day withdrawal in Graves' disease Endocrine J 53 603 607 10.1507/endocrj.K06-057
69. MA Walter M Crist-Crain C Schindler J Mueller-Brand B Mueller 2006 Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison Eur J Nucl Med Mol Imaging 33 730 737 10.1007/s00259-006-0092-8 16607544
70. MJ Reinhardt I Brink AY Joe D von Mallek S Ezziddin H Palmedo, et al. 2002 Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome Eur J Nucl Med 29 1118 1124 10.1007/s00259-002-0877-3
71. S Dunkelmann V Neumann U Staub P Groth H Kuenstner C Schuemichen 2005 Results of a risk adapted and functional radioiodine therapy in Graves' disease Nuklearmedizin 44 238 242 16400383
72. MJ Reinhardt A Joe D von Mallek M Zimmerlin A Manka-Waluch H Palmedo, et al. 2002 Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake Eur J Nucl Med Mol Imaging 29 480 485 10.1007/s00259-002-0877-3 11914885
73. S Dunkelmann D Endlicher A Prillwitz F Rudolph P Groth C Schuemichen 1999 Results of a TcTUs-optimized radioiodine therapy of multifocal and disseminated functional thyroid autonomy Nuklearmedizin 38 131 139 10488479
74. C Reiners P Schneider 2002 Radioiodine therapy of thyroid autonomy Eur J Nucl Med 29 Suppl 2 S471 S478 10.1007/s00259-002-0910-6
75. M Reinhardt B Kim M Wissmeyer F Juengling H Brockmann D von Mallek, et al. 2006 Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy? Eur J Nucl Med Mol Imaging 33 608 612 10.1007/s00259-005-0051-9 16541268
76. JMB Manders FHM Corstens 2002 Radioiodine therapy of euthyroid multinodular goitres Eur J Nucl Med 29 Suppl2 S466 S470 10.1007/s00259-002-0876- 4
77. O Cohen J Ilany C Hoffman D Olchovsky A Karasik E Goshen, et al. 2006 Low dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients Eur J Endocrinol 154 243 252 10.1530/eje.1.02094 16452537